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Diabetic Nephropathy S3from week 12 to week 20 on db/db mice and in cultured mouse tubular
epithelial cells (mTECs) under high AGE conditions.
Results: lncRNA_5318 was highly upregulated in db/db mice that developed
renal fibrosis with impaired renal function. Upregulation of lncRNA_5318 was
tightly associated with upregulation of renal TGF-b1 and massive activation of
Smad3on thediabetic kidney,whichwas further confirmed inmTECs stimulated
with AGE. ChiP assay demonstrated a Smad3 binding site on lncRNA_5318 pro-
moter. Knockdown of Smad3 from mTECs blocked AGE-induced lncRNA_5318,
revealing a Smad3-dependent mechanism in regulating lncRNA_5318 expres-
sion. Moreover, knockdown of lncRNA_5318 was able to inhibit AGEs-induced
Smad3-dependent fibrosis. Importantly, Treatment in db/db mice with shRNA
lncRNA_5318 showed a protective effect on diabetic kidney injury by inhibiting
an increase in urinary albumin excretion and renal fibrosis including collagen I
and collagen IV expression over week12-20 on db/db mice.
Conclusion: lncRNA_5318 is a Smad3-dependent lncRNA that functions to
promote Smad3 dependent renal fibrosis under diabetic conditions.
Blockade of lncRNA_5318 may represent a novel therapy for DN.http://dx.doi.org/10.1016/j.hkjn.2015.08.010
0041
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Objective: Transforming growth factor (TGF)-b/Smad3 signaling is highly
activated in the diabetic kidney in patients with type-2 diabetes. However,
the precise role of Smad3 in the pathogenesis of type-2 diabetic nephropa-
thy remains largely unclear, which was investigated in this study by specif-
ically deleting Smad3 from db/db mice.
Methods: Smad3 knockout (KO)-db/db mice were generated by crossing the
db/mmouse to the Sma3+/mouse. This cross-breeding resulted in five groups
of mice: Smad3/db/db, Smad3+/+ db/db, Smad3+/db/db, Smad3+/+db/m,
and Smad3/db/m mice. Groups of 8 mice were scarified at weeks 8, 20,
and 32 and effect of deleting Smad3 gene on levels of fasting blood glucose,
renal function, histological injury, and molecular pathology were examined.
Results: Compared to Smad3+/+db/m and Smad3/db/m mice that
exhibited normal levels of blood glucose and urinary albumin excretion
over the 32-week time course, Smad3+/+ db/db, Smad3+/db/db developed
progressive higher levels of fasting blood glucose (15e40 mmol/L) with sig-
nificant diabetic kidney injury including increased microalbuminuria and
deposition of collagen I, IV. In contrast, deletion of Smad3 from db/db
mice (Smad3/db/db) prevented an increase in blood glucose over the
32-week time course and protected against the development of diabetic kid-
ney injury with normal renal function and histology without evidence for
renal fibrosis and inflammation. In addition, Smad3 deficiency also pre-
vented renal inflammation by inactivating NF-kB/ signaling and therefore
blunting upregulation of TNF-a, MCP-1, and macrophage infiltration.
Conclusion: Deletion of Smad3 prevents the development of type-2 diabetic
nephropathy. This novel finding strongly suggests that targeting Smad3 may
be a novel and effective therapy for type-2 diabetic complications clinically.http://dx.doi.org/10.1016/j.hkjn.2015.08.011
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Objective: GPR124 is a very recently identified G protein-coupled receptor
(GPCR), which has a large ectodomain and belongs to the adhesion GPCR sub-
family. GPR124 is crucial for the growth of solid tumors and also important
for angiogenesis. However, the functional role of GPR124 in the kidney and
the contribution of GPR124 to the pathogenesis of diabetic nephropathy (DN)remain unclear. The present study was designed to explore the role of
GPR124 in podocytes in DN.
Methods: Diabetes was induced by tail-vein injection of streptozotocin (STZ)
in podocyte-specific deletion of GPR124 mice. Glomerular function was
assessed by measuring proteinuria, and podocyte morphology was evaluated
by transmission electron microscopy (TEM).
Results: We found that GPR124 was down-regulated in the kidney from dia-
betic mice, db/db mice, and in kidney biopsies from diabetic patients. In
cultured podocytes, high-glucose (HG) significantly decreased GPR124
expression in podocytes. Overexpression of GPR124 ameliorated HG-reduced
the expressions of ZO-1 and nephrin in podocytes. Furthermore, Co-IP results
revealed that GPR124 directly binds to ZO-1 in WT mice. HG or and gene
silencing of GPR124 can reduce ZO-1 expression in podocyte. Consistently,
podocyte-specific deletion of GPR124 exacerbated renal injury as evidenced
by high albuminuria and foot process effacement in mice.
Conclusion: Our study for the first time demonstrates that GPR124 is an essen-
tial factor for podocyte adhesion to glomerular basement membrane (GBM). A
better understanding of the biological activities of GPR124 in the kidney may
open new therapeutic avenues for the treatment of glomerular diseases.http://dx.doi.org/10.1016/j.hkjn.2015.08.012
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Objective: Recent study found that miRNAs are involved in diabetic kidney dis-
ease (DKD). The objective of this study is to determine the role ofmiR302a-3p in
the process of renal epithelial-mesenchymal transition (EMT) in DKD.
Methods: The levels of miR302a-3p in the plasma of DKD patients were
detected by realtime PCR and then the relationship of miR302a-3p and UAE
or eGFR were analyzed. Secondly, miR302a-3p expression was determined in
HK-2 cells treated with high glucose for different time. And then miR302a-3p
mimics and inhibitor were transfected to HK-2 cells following exposure to
high glucose and low glucose respectively. The expressions of ZO-1, vimentin
and ZEB-1 were determined by realtime PCR and western blot.
Results:TheexpressionofcirculatingmiR-302a-3pwas significantly increased in
the diabetes mellitus (DM) group (nZ 22) compare with control (healthy per-
sons, n Z 30) and then decreased in the early stage of diabetic nephropathy
(DNE) group (nZ 20). Furthermore, its expression in clinical diabetic nephrop-
athy (DNC) group (nZ 18)was decreased significantly comparedwith DMgroup.
Circulating miR-302a-3p had negative relevance with UAE in DNE group (rZ -
0.649, P Z 0.002) and DNC group (r Z -0.681, P Z 0.006;); Circulating miR-
302a-3p had positive relevance with eGFR in DNC group (r Z 0.486,
PZ 0.041). In vitro, miR-302a-3p expression in HG group increased at 6 h and
aescended to the highest level at 12 h and then gradually decreased from 24 h
to 72 h.More interesting, ZEB1protein expression had anopposite changewhich
gradually decreased from 6 h to 24 h and then gradually increased from 48 h to
72 h.Moreover, overexpression ofmiR-302a-3p suppressed expression of ZEB1 in
the post-transcriptional level and reversed high glucose-mediated downregula-
tionof E-cadherin andupregulationof vimentin.Meanwhile, loss ofmiR-302a-3p
expression can lead to EMT of HK-2 cells just as high glucose stimulation.
Conclusion: miR-302a-3p may play a protective role by targeting ZEB1 in
renal epithelial- mesenchymal transition in DKD.http://dx.doi.org/10.1016/j.hkjn.2015.08.013
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Diabetic nephropathy (DN) is the leading cause of end stage renal disease.
TGF-beta signaling plays an important role in DN but how persistent organic
S4 Diabetic Nephropathypollutants (POP) affects renal injury has not been elucidated. Perfluorooc-
tane sulfonate (PFOS) is an emerging POP in China. PFOS is readily absorbed
after oral exposure and accumulates primarily in the serum, kidney, and
liver. Toxicological studies on animals indicate its potential developmental,
reproductive and systematic effect. PFOS can activate peroxisome prolifer-
ator-activated receptor alpha (PPARalpha) and may act via PPARalpha to
produce some of their effects. In this study, we examined whether PFOS
enhanced renal injury in vitro under diabetic condition. Our results
demonstrated that the presence of PFOS was able to enhance the expression
of fibrotic markers and enhanced oxidative stress in renal tubular epithelial
cells under diabetic condition. PFOS also promoted the apoptosis of the
renal tubular epithelial cells. This study demonstrated that presence of PFOS
promoted renal injury in vitro under diabetic condition, suggesting that an
environmental pollutant is associated with renal injury in DNhttp://dx.doi.org/10.1016/j.hkjn.2015.08.014
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Objective: To evaluate the relationship between tubulointerstital injury and
hyperphosphatemia in the patients with type 2 diabetes and diabetic ne-
phropathy (T2DN), and investigate the association of hyperphosphatemia
with the renal outcome, especially in the T2DN patients with
eGFR60 ml/min per 1.73 m2.
Methods: A total of 396 patients with T2D and biopsy-proven DN from Nanj-
ing DN registration system who received follow-up for at least 1 year were
recruited and median 5-year follow-up. Renal outcomes were defined by
progression to end-stage renal disease and doubling of serum creatinine.
Results: Of the participants, the baseline eGFR was 73.86  33.52 mL/min
per 1.73 m2. The levels of the urinary tubulointerstitial injury markers
including the NAG, RBP and NAGL were significantly difference among quin-
tiles of serum phosphorus (P < 0.01). The participants whose eGFR90 ml/
min per 1.73 m2 had a higher rate of tubulointerstitial injury (interstitial
fibrosis tubular atrophy scores of 2 and 3, P Z 0.005; interstitial inflamma-
tion scores of 1 and 2, P Z 0.035) in hyperphosphatemia (>1.45 mmol/L)
group than in lower phosphorus group (<1.17 mmol/L). Participants with
baseline levels of serum phosphorus in higher quintiles had a higher cumula-
tive incidence of ESRD (log-rank, P < 0.01). In the analyses adjusted by age,
sex, diabetes status, BP, FBG, BMI, proteinuria, cholesterol, and eGFR, the
relationship between higher serum phosphorus and an increased risk of
ESRD remained. The association between serum phosphorus and ESRD risk
persisted and was stronger when the sample was restricted to those with a
baseline eGFR equal to 60e90 mL/min per 1.73 m2, but not when it was
restricted to patients with a baseline eGFR of 30e60 mL/min per 1.73 m2.
Conclusion: These findings indicated the baseline serum phosphorus is asso-
ciated with tubularinterstitial injury of T2DN. And serum phosphorus
>1.45 mmol/L is an independent risk factor of ESRD in T2DN, especially in
the patients with eGFR60 ml/min per 1.73 m2.http://dx.doi.org/10.1016/j.hkjn.2015.08.015
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Objective: Serum cystatin C is an alternative to serum creatinine for esti-
mating glomerular filtration rate (GFR), however, the utility of estimated
GFR from combination of serum creatinine and cystatin C as marker topredict long-term renal outcome is uncertain, particularly in the Type 2 dia-
betic nephropathy (DN).
Methods: A total of 501 patients (The National Clinical Research Center of
Kidney Diseases, 2003e2011) were recruited in prospective cohort study.
Follow-up was 5-year. Renal outcome was defined by eGFRcre-
cys < 15 ml/min per 1.73 m2 or renal replacement therapy.
Results: The distributions of standardized serum cystatin C with eGFRcre and
eGFRcre-cys are shown in Figure 1. Kaplan-Meier curves showed significantly
increased renal end points with higher quartile of cystatin C (p < 0.001) and
lower eGFRcre-cys (p < 0.001). The highest AUROCs was eGFRcre-cys in pre-
dicting the renal endpoint compared with eGFRcre or eGFRcys. The best cut-
off value for predicting the renal endpoint was 29.28% decline in the 24-
month, which value showed 79.6% sensitivity and 82.6% specificity. Cox
regression models with restricted cubic splines were shows a change of
30% in eGFRcre-cys was associated with adjusted HRs for ESRD of 27.92
(95%CI, 3.95e197.48) over 2-year.
Figure 1. The population of estimated GFRcre, GFRcys and GFRcre-cys
equation.
Conclusion: eGFRcre-cys was a precision, and accuracy marker in the pre-
dicting of the renal outcome and 30% decline of eGFRcre-cys over 2 years
was strongly associated with the risk of ESRD, suggesting it could be used
as an alternative end point in T2DN.http://dx.doi.org/10.1016/j.hkjn.2015.08.016
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Objective: Tangshen formula (TSF), as a traditional Chinese medicine, has
been shown to have good clinical efficacy in diabetic nephropathy (DN)
treatment. In this study, the potential molecular targets of TSF were
explored in db/db mice treated with TSF.
Methods: db/db mice were treated with or without TSF by gavage for
12 weeks, with db/m mice as a control. Serum glucose, 24h-albuminuria and
histology were detected. Gene expression microarray was carried to detected
the gene expression profile in 3 groups mice kidney tissues.
Results: The results showed that treatment with TSF significantly reduced
serum glucose and the excretion of urinary albumin in db/db mice, and
attenuated secretion of extracellular matrix in renal glomeruli. Clustering
analysis indicated the three groups could be their respective together for
a class and almost 400 differentially expressed genes were identified in
db/db mice and TSF-treated mice. These genes were mainly involved in
